We have previously found incomplete sarcomeres and acetylcholinesterase activity in the myoblasts of the myotome of the rabbit at day 13 of gestation. We now report that an acetylcholine (ACh)-synthesizing enzyme and the nicotinic receptor are present at this stage as well. A study of the myotome using [125I]alpha-bungarotoxin shows that the mononucleated myoblasts have alpha-bungarotoxin binding sites before they migrate away to form multinucleated myotubes. Choline acetylcholinesterase activity and/or a different ACh-synthesizing enzyme are found at early stages of development, even before the spinal nerve has formed. An ACh-synthesizing enzyme is present in the notochord, a neural tube-dorsal root ganglion preparation, as well as in rows of myotomes separated from the latter preparation. Assays of isolated myotomes with very little adherent mesenchyme indicate that the enzyme is located either within the myotome or in its immediate vicinity. Cholinergic components, therefore, are associated with the mononucleated myoblasts of the myotome before they fuse to form myotubes and before they receive their permanent innervation.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cne.902220310 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Activation of a non-neuronal cholinergic system in visceral white adipose tissue of obese mice and humans.
Mol Metab
January 2024
Department of Experimental and Clinical Medicine, Marche Polytechnic University, 60126 Ancona, Italy; Center of Obesity, Marche Polytechnic University-United Hospitals, Ancona, Italy. Electronic address:
Article Synopsis
- This study aimed to identify sources of acetylcholine (ACh) in white adipose tissue (WAT) and to investigate the activation of a non-neuronal cholinergic system in obese, inflamed WAT.
- Diet-induced obesity was found to increase the expression of choline acetyltransferase (ChAT), mainly in macrophages within mouse epididymal WAT, suggesting these immune cells might produce ACh.
- In human adipocytes, ACh reduced inflammatory markers and enhanced glucose uptake, indicating a potential therapeutic role for ACh in obesity-related inflammation.
Effectiveness of Combinational Treatments for Alzheimer's Disease with Human Neural Stem Cells and Microglial Cells Over-Expressing Functional Genes.
Int J Mol Sci
May 2023
College of Veterinary Medicine, Chungbuk National University, Cheongju 28644, Chungbuk, Republic of Korea.
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases. In AD patients, amyloid-β (Aβ) peptide-mediated degeneration of the cholinergic system utilizing acetylcholine (ACh) for memory acquisition is observed. Since AD therapy using acetylcholinesterase (AChE) inhibitors are only palliative for memory deficits without reversing disease progress, there is a need for effective therapies, and cell-based therapeutic approaches should fulfil this requirement.
View Article and Find Full Text PDFA novel transgenic mouse model expressing primate-specific nuclear choline acetyltransferase: insights into potential cholinergic vulnerability.
Sci Rep
February 2023
Department of Physiology and Pharmacology and Robarts Research Institute, Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, N6A 5K8, Canada.
The acetylcholine (ACh) synthesizing enzyme choline acetyltransferase (ChAT) is an important cholinergic neuronal marker whose levels and/or activity are reduced in physiological and pathological aging. One isoform of ChAT, 82-kDa ChAT, is expressed only in primates and found primarily in nuclei of cholinergic neurons in younger individuals, but this protein becomes mostly cytoplasmic with increasing age and in Alzheimer's disease (AD). Previous studies suggest that 82-kDa ChAT may be involved in regulating gene expression during cellular stress.
View Article and Find Full Text PDFIdentification of cholinergic cells with chemosensory traits in the porcine uterus.
Cell Tissue Res
April 2022
Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, 1333 Center Drive, PO Box 100144, Gainesville, FL, 32610, USA.
Chemosensory cells are specialized epithelial cells that act as sentinels near body entry sites. The majority of these cells express a cholinergic phenotype and utilize the taste signaling system to monitor the mucosal environment for potentially harmful substances, triggering protective reflexes. We report the identification of cells with a putative chemosensory role in the uterus.
View Article and Find Full Text PDFPeripheral Nerve Impairment in a Mouse Model of Alzheimer's Disease.
Brain Sci
September 2021
Institute of Biochemistry and Cell Biology (IBBC), National Research Council of Italy (CNR), Via E. Ramarini, 00015 Rome, Italy.
Article Synopsis
- Sarcopenia is the loss of muscle mass and strength that often occurs in the early stages of Alzheimer's disease (AD), which involves the buildup of amyloid β (Aβ) aggregates.
- Researchers studied Tg2576 mice, a model known for Aβ accumulation, to investigate the effects on cholinergic innervation in skeletal muscle, particularly the tibialis anterior muscle.
- The study found that Tg2576 mice had significantly reduced neuronal innervation and smaller synaptic areas with lower choline acetyltransferase (ChAT) content compared to normal mice, suggesting a link between Aβ accumulation and sarcopenia through cholinergic loss.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!